---
$id: https://graph.org.ai/products/commodity/51142420
$type: Product
source: UNSPSC
code: "51142420"
title: "Ergotamine"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ergotamine

**UNSPSC Code**: 51142420
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C33H35N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PR834Q503T, chemically known as 5-benzyl-12-hydroxy-2-methyl-3,6,18-trioxoergotaman but generally known as ergotamine, which bears US NIH Compound Identifier 3251. European Medicines Agency schedules Ergotamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06598MIG. The term ERGOTAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules ergotamine in its Anatomical Therapeutic Chemical (ATC) Classification. ERGOTAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ergotamine under HS 29396200 and SITC 54146. As of Q4 2014, ERGOTAMINE remains the US FDA Preferred Term for this commodity. Ergotamine bears US NLM identifiers UMLS ID C0014710 and NCI Concept Code C61751. SMILES: O1C2(O)N(C(C(=O)N3C2CCC3)CC2CCCCC2)C(=O)C1(NC(=O)C1CN(C2C(=C1)C1C3C(C2)C[NH]C3CCC1)C)C.

